China Interventional Cardiovascular Device Industry Report, 2010
  • Jan/2011
  • Hard Copy
  • USD $1,800
  • Pages:73
  • Single User License
    (PDF Unprintable)       
  • USD $1,700
  • Code: ZT004
  • Enterprise-wide License
    (PDF Printable & Editable)       
  • USD $2,300
  • Hard Copy + Single User License
  • USD $2,000
In recent years, the prevalence rate of cardiovascular disease has increased year by year. According to the data issued by Ministry of Health of the People’s Republic of China, there were 20 million patients with coronary artery disease in China 2008, and the number rises at the annual growth of more than 1 million. The growth spurt of the patients suffering from heart disease has stimulated the fast growing demand for interventional cardiology operations and coronary stents.

In China, the number of PCI operation cases rose from 25,000 in 2002 to 242,000 in 2009; the coronary stent implantation amount increased from 40,000 sets in 2002 to 387,000 in 2009. In 2009, Chinese market size of interventional cardiovascular device (by terminal sales revenue of hospitals) reached RMB8.16 billion, up 30% from a year earlier.

PCI Operation Cases and Coronary Stent Implantation Amount in China, 2002-2012 (Unit: 1,000 cases)
Source: China Association for Medical Devices Industry, ResearchInChina

Interventional cardiovascular device includes coronary stent and surgical support equipment. In 2009, Chinese coronary stent market valued RMB5.71 billion; and the market size of surgical support equipment (including balloon catheter, catheter, and guide wire) hit RMB2.46 billion. The ratio of the two markets was about 7:3.

Before 2004, foreign companies dominated Chinese coronary stent market. Because of incessantly exploring core technologies and accumulating experience, Chinese enterprises enjoy the rising market shares yearly and even more than foreign counterparts by virtue of advantages in price and channel. By the amount of implantation, domestic enterprises swept about 77.7% market shares in 2009, while foreign peers took approximately 22.3%; by the terminal sales revenue of hospitals, domestic enterprises held around 66.8% market shares in 2009, while foreign ones occupied 33.2% or so.

Coronary Stent Market Shares in China (by Sale of Hospitals), 2009
Source: MicroPort, ResearchInChina

In 2009, MicroPort Scientific, Lepu Medical and JW Medical ranked the top three in terms of the market share of coronary stent; by the terminal sales revenue of hospitals, MicroPort Scientific, Lepu Medical and JW Medical took the market share of 25.1%, 20.5% and 18.5% respectively. Remarkably, MicroPort and Lepu are with the diversified product lines of interventional cardiovascular device, and both of them focus on coronary stent and also pay attention to angiography catheter, guidewire, sheath introducer kit, etc, with the objective of ultimately covering the entire field of interventional cardiovascular devices. In addition, MicroPort and Lepu are making more efforts in the R&D of interventional cardiovascular devices. MicroPort is now developing the third-generation drug-eluting stent “Firehawk” , while Lepu is developing a new generation of magnesium alloy biodegradable stents.

However, in surgical supporting device market consisting of balloon catheter, catheter and guidewire, due to technical limitations, only less than 20% of products are made in China. The market is dominated by Cordis, J & J, Medtronic, Boston and other foreign brands. Yet, Chinese enterprises may simulate the development modes of those foreign companies. MicroPort, Lepu, Fisuntech, TemMed and other companies are enhancing R&D and production of surgical supporting instruments. In the future, the competition in the market of interventional cardiovascular supporting devices will intensify.

The report is based on social, economic and policy environments, the overall operation, market competition and development trends of Chinese interventional cardiovascular device industry. It not only studies such market segments as coronary stents, balloon catheters, catheters, guidewires, assistive devices and others in China, but also analyzes the operation and development of 12 major interventional cardiovascular device manufacturers including J & J Cordis, Medtronic, Boston Scientific, Abbott Guidant, B. Braun, MicroPort, Lepu, JW, Yinyi, OrbusNeich, Fisuntech, SCW Medical.
1 Overview of Interventional Cardiovascular Device Industry 
1.1 Definition
1.2 Product Category and Application
1.3 Industry Chain

2 Development of Interventional Cardiovascular Device Industry in China
2.1 International Environment
2.2 Industry Overview
2.3 Supply and Demand
2.4 Market Scale and Gross Profit
2.5 Competition Pattern
2.6 Related Policies
2.6.1 Laws and Regulations
2.6.2 Development Policies
2.6.3 Sales Policies
2.7 Import
2.8 Development Trends
2.8.1 Health Care Reform Improves People’s Spending Power
2.8.2 Diversification of Product Lines

3 Interventional Cardiovascular Market Segments
3.1 Coronary Stent
3.1.1 Market Overview
3.1.2 Drug-eluting Stent   
3.1.3 Bare Metal Stent 
3.1.4 Bioabsorbable Stent 
3.2 Balloon Catheter
3.2.1 Market Overview
3.2.2 Supply & Demand
3.3 Catheter
3.3.1 Market Overview
3.3.2 Sale
3.4 Guidewire 
3.4.1 Market Overview
3.4.2 Sale
3.5 Sheath Introducer Kit and Auxiliary Device
3.5.1 Market Overview
3.5.2 Sale

4 Foreign Production Enterprises
4.1 Cordis, J&J
4.1.1 Profile
4.1.2 Operation
4.1.3 Operation in China
4.2 Medtronic
4.2.1 Profile
4.2.2 Operation
4.2.3 Operation in China
4.3 Boston Scientific
4.3.1 Profile
4.3.2 Operation
4.3.3 Operation in China
4.4 Guidant , Abbott
4.4.1 Profile
4.4.2 Operation
4.4.3 Operation in China
4.5 B.Braun
4.5.1 Profile
4.5.2 Operation
4.5.3 Operation in China

5 Chinese Production Enterprises
5.1 MicroPort Scientific
5.1.2 Operation
5.1.3 Development
5.2 Lepu Medical
5.2.1 Profile
5.2.2 Operation
5.1.3 Development
5.3 JW Medical
5.3.1 Profile
5.3.2 Operation
5.3.3 Development
5.4 Yinyi
5.4.1 Profile
5.4.2 Operation
5.4.3 Features
5.5 OrbusNeich
5.5.1 Profile
5.5.2 Operation
5.5.3 Features
5.6 Fuji Suntech
5.6.1 Profile
5.6.2 Operation
5.6.3 Development
5.7 SCW Medical
5.7.1 Profile
5.7.2 Operation
5.7.3 Development
Types and Functions of Interventional Cardiovascular Devices
Types and Characteristics of Cardiovascular Stents
China Interventional Cardiovascular Device Industry Chain
Global Market Scale of Interventional Cardiology Devices, 2005-2012 
Coronary Stent Sales Volume of Major Brands in the World, 2009
Scale and Growth Rate of Chinese Medical Device Market, 2002-2009
Total Number and Growth Rate of Hospitals in China, 2005-2010
Main Interventional Cardiovascular Device Companies in China
Number of People Aged 65 or above and Proportion in Some Countries, 2010
Prevalence of Heart Disease and Hypertension in China, 1993-2008
Number of PCI Operation Cases in China, 2002-2012
Coronary Stent Implantation Number in China, 2002-2012
Interventional Cardiovascular Device Market Size in China, 2009
Gross Margins of Major Interventional Cardiovascular Device Manufacturers in China, 2007-2009
Coronary Stent Market Shares in China (by Implantation Volume and Sales of Hospitals), 2009
Major Laws and Regulations concerning Medical Device Industry in China
Policies Related to Interventional Cardiovascular Device Industry
Sales Channels of Interventional Cardiovascular Devices in China
Average Price Comparison bettwen Coronary Stents Procured by Ministry of Health of the P.R.C and the Imported Ones, 2008-2010
Import of Major Interventional Medical Devices and Materials in China, 2008
Charges of Interventional Operations paid by Health Insurance in Beijing, Shanghai and Guangzhou, 2010
Urban Health Insurance Participants and Growth Rate in China, 2000-2009
Equipment Product Line Layout of MicroPort, Lepu and JW Medical
Coronary Stent Market Scale in China, 2007-2015
Coronary Stent Market Shares in China (by Volume of Implanted Stents), 2009
Coronary Stent Market Shares in China (by Sale of Hospitals), 2009
Drug-eluting Stents in China, 2010
Some Bare Metal Stents in China, 2010
Demand for Coronary Artery Balloon Catheters in China, 2002-2009
Average Purchase Price of Balloon Catheters in China, 2010
Some Rapid Exchange Expansion Balloon Catheters in China, 2010
Average Purchase Price of Catheters in China, 2010
Guide Catheters in China, 2010
Average Purchase Price of Guidewires in China, 2010
Some Guidewires in China, 2010
Average Purchase Price of Sheath Introducer Kit and Auxiliary Equipment in China, 2010
Medical Device Revenue, Cordis Revenue and Proportion of Johnson & Johnson, 2007-2010
Cardiovascular Product Revenue, Coronary Stent Revenue and Proportion of Medtronic, FY2007-FY2011
Main Operating Indicators of Medtronic (Shanghai), 2007-2008
Total Revenue, Coronary Stent Revenue and Proportion of Boston Scientific, 2008-2010
Revenue and Growth Rate of of Abbott's Vascular Device Sector, 2008-2010
Revenue and Growth Rate of of B. Braun Aesculap, 2006-2009
Main Operating Indicators of B.Braun (Suzhou), 2008 
Operating Income, Gross Margin and Revenue Growth Rate of MicroPort Scientific, 2007-2010         
Revenue (by Product) of MicroPort Scientific, 2007-2010
Revenue (by Region) of MicroPort Scientific, 2007-2010    
R&D Expenditure and Its proportion in Sales Revenue of MicroPort Scientific, 2007-2010
R &D of New Products of MicroPort Scientific, by Sep 2010
Capacity, Actual Output and Utilization of Stents and Catheters of MicroPort Scientific, 2007-2010
Operating Income, Gross Margin and Revenue Growth Rate of Lepu Medical, 2007-2010   
Sales Gross Margin (by Product) of Lepu Medical, 2007-2010
Revenue (by Product) of Lepu Medical, 2008-2010       
Revenue (by Region) of Lepu Medical, 2010
R &D Expenditure and Its proportion in Sales Revenue of Lepu Medical, 2007-2009
R&D Layout of Lepu Medical 
Operating Income and Gross Margin of JW Medical, 2007-2008
Main Operating Indicators of Liaoning Biomedical Materials, 2008
Operating Income, Gross Margin and Revenue Growth Rate of OrbusNeich, 2005-2008
Export Value of OrbusNeich, 2005-2008
Main Operating Indicators of Fuji Suntech, 2008
Operating Income, Gross Margin and Revenue Growth Rate of SCW Medical, 2005-2008         
Export Value of SCW Medical, 2005-2008

China Blood Product Industry Report, 2020-2027

With the adjustment in the catalog of medicines covered by national medical insurance system, the scope and reimbursement ratio of almost all blood products for clinical use grow tremendously, which h...

China Medical Robot Industry Report, 2020-2026

Medical robot is the most promising segment of service robot market. By one estimate, globally 7,200 units of medical robots were sold and valued at $2.58 billion in 2019, compared with 5,100 units (u...

China In Vitro Diagnostic (IVD) Industry Report, 2019-2025

In vitro diagnosis (IVD) as a good way to make a rapid and definite diagnosis of diseases early, plays an increasingly crucial role in clinical medicine and related medical research fields. China’s IV...

China Aged Care Industry Report, 2019-2025

China’s society has aged before it gets rich. By the end of 2018, people aged over 60 had numbered 249.5 million in the country, or 17.9% of the total population, of which those aged over 65 were 167 ...

China Dental Industry Report, 2019-2025

Nowadays, the Chinese people have a growing awareness of oral health and healthy behaviors. 60.1% of residents have knowledge about oral health; 24.1% of 5-year-old children and 31.9% of 12-year-old c...

China Hospital Industry Report,2019-2025

The people’s growing awareness of health care and the acceleration of population aging have brought prosperity to China’s hospital industry. As of February 2019, there had been a total of 33,000 hospi...

China Dental Industry Report, 2017-2021

As living standards continue to improve and the awareness of oral health grows, consumers’ demand for dental services has kept increasing and the dental industry in China has witnessed robust developm...

China Interferon Industry Report, 2016-2021

Interferon is mainly used for the treatment of hepatitis B, hepatitis C, multiple sclerosis, condyloma acuminatum and other diseases. Wherein, IFN-α is mainly suitable for curing hepatitis B and hepat...

China Hospital Industry Report,2016-2020

In recent years, "Opinions on Promoting the Development of Health Service Industry" and other related policies, the people’s growing awareness of health care and the acceleration of population aging h...

China Aged Care Industry Report, 2016-2020

China entered the aging society early in 1999. By the end of 2015, China’s population aged over 60 reached 222 million and the old-age dependency ratio 13.9%. By 2020, China’s population aged over 60 ...

China Medical Robotics Industry Report, 2016-2020

Medical robotics can be used in surgery, rescue, transport, care, rehabilitation, dispensing and so on for the sick and wounded. Especially, surgical, rehabilitation and dispensing robots are the R &a...

China Dental Industry Report, 2016-2020

The dental industry refers to medical industrial chain on the basis of oral medical consumption, consisting mainly of dental apparatus (equipments and consumables), dental medical services, etc. With ...

China Medical Imaging Diagnosis Industry Report, 2015-2019

Against the background of a surge in social demand, handsome profit and the favorable opportunity brought by health care reform, the medical imaging industry, especially medical imaging equipment indu...

China Heparin Industry Report, 2015-2018

As the world's largest heparin API producer and exporter, China seizes about 80% share of the global heparin API market. After the explosive growth in 2008-2010, the stagnant international market and ...

Global and China Stem Cell Industry Report, 2015-2018

Stem cells are undifferentiated biological cells that can differentiate into specialized cells and can divide (through mitosis) to produce more stem cells. Currently, stem cells are used to treat hund...

China Hospital Industry Report, 2015-2018

Stimulated by the demand, the number of hospitals in China rose from 21,979 in 2011 to 26,479 at the end of May 2015, an increase of 4,500 in total. Among them, public hospitals showed an overall decl...

China Independent Clinical Laboratory Industry Report, 2015-2018

The independent clinical laboratory originated from the U.S. and is relatively mature in developed countries/regions like North America, Europe, and Japan, whose independent clinical laboratory market...

China Medical Robot Industry Report, 2014-2018

Medical robots can be applied to surgeries, rescue, transport, nursing and rehabilitation of the sick and wounded. Wherein, surgery and rehabilitation robots are two striking market segments. Due to ...

2005- All Rights Reserved 京ICP备05069564号-1 京公网安备1101054484号